Merge Technologies Incorporated Releases MergeReport™, a Radiologist Workstation Application. Application enables primary diagnostic interpretation; sixth module of PACSbuilder completes modular system to drive automated medical image and information workflow.
Milwaukee, WI, June 28, 2002

Milwaukee, WI, June 28, 2002 - Merge Technologies today announced the release of MergeReport, a new product within its PACSbuilder suite of radiology workflow solutions. MergeReport provides exceptional navigation and viewing tools with a simple user interface, providing radiologists with the comprehensive information set that is needed to interpret images in an integrated application, including patient demographics, images, and relevant prior images and reports.

One of the most innovative features of MergeReport is its ability to manage clinical and departmental workflow. With MergeReport, radiologists can establish workflow preferences that support the individual style in which they work. MergeReport delivers appropriate cases to each radiologist via user-defined criteria such as type of studies by anatomy, modality, or location. Based upon the established criteria, the digital images are quickly presented to the radiologist, who can utilize a comprehensive set of tools that optimize viewing of the image. In addition, radiologists can establish individual criteria for relevant prior images and reports, which are automatically retrieved and presented for viewing in conjunction with the image to be interpreted.

"MergeReport was designed specifically to enhance the clinical practice of radiology," said Stephen Herman, MD, Merge's Chief Medical Officer. "The comprehensive information and the flexibility of its delivery assures that radiologists have access to all the information necessary to interpret studies, while maintaining optimal productivity. MergeReport's elegant design delivers both clinical and economic impact. In addition, PACSbuilder's scalable platform is designed to easily add new functionality as the practice of clinical radiology grows."

Shands Jacksonville Medical Center utilizes MergeReport throughout their Radiology Department. "MergeReport has provided us with an innovative solution for organized, fast, and clinically appropriate workflow," said Daniel Siragusa, MD, a radiologist at Shands-Jacksonville Medical Center, Jacksonville, Florida. "MergeReport's customization features provide individual preferences which increase both productivity and user satisfaction, while creating a common workflow that quickly and appropriately serves our referring physicians and their patients."

Rich Linden, Merge's President and CEO said, "The development of MergeReport is consistent with our focus on clinically robust, technically innovative applications that combine operational efficiency with clinical efficacy. It is another milestone in Merge's continuing focus on HIPAA-ready radiology workflow solutions using the Integrated Healthcare Enterprise (IHE) model."

Press Contact
Attn: Beth Frost-Johnson Merge Healthcare 6737 West Washington St. Suite 2250 Milwaukee, WI 53214		Phone: 1-(414) 977-4254
Email Address: marketing@merge.com
Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.